A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis
Clinical trial NCT00244452 · COMPLETED
Trial details
- NCT number
- NCT00244452
- Sponsor
- Solvay Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2006-09-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.